Becton Dickinson Revenue 2006-2018 | BDX

Becton Dickinson annual/quarterly revenue history and growth rate from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Becton Dickinson revenue for the quarter ending June 30, 2018 was $4.278B, a 40.96% increase year-over-year.
  • Becton Dickinson revenue for the twelve months ending June 30, 2018 was $14.747B, a 21.29% increase year-over-year.
  • Becton Dickinson annual revenue for 2017 was $12.093B, a 3.12% decline from 2016.
  • Becton Dickinson annual revenue for 2016 was $12.483B, a 21.41% increase from 2015.
  • Becton Dickinson annual revenue for 2015 was $10.282B, a 21.74% increase from 2014.
Becton Dickinson Annual Revenue
(Millions of US $)
2017 $12,093
2016 $12,483
2015 $10,282
2014 $8,446
2013 $8,054
2012 $7,708
2011 $7,584
2010 $7,124
2009 $6,987
2008 $6,898
2007 $6,283
2006 $5,738
2005 $5,341
Becton Dickinson Quarterly Revenue
(Millions of US $)
Q3 2018 $4,278
Q2 2018 $4,222
Q1 2017 $3,080
Q4 2017 $3,167
Q3 2017 $3,035
Q2 2017 $2,969
Q1 2016 $2,922
Q4 2016 $3,232
Q3 2016 $3,198
Q2 2016 $3,067
Q1 2015 $2,986
Q4 2015 $3,060
Q3 2015 $3,120
Q2 2015 $2,051
Q1 2014 $2,051
Q4 2014 $2,202
Q3 2014 $2,157
Q2 2014 $2,072
Q1 2013 $2,015
Q4 2013 $2,101
Q3 2013 $2,053
Q2 2013 $2,000
Q1 2012 $1,900
Q4 2012 $1,967
Q3 2012 $1,981
Q2 2012 $1,929
Q1 2011 $1,832
Q4 2011 $1,868
Q3 2011 $1,952
Q2 2011 $1,922
Q1 2010 $1,842
Q4 2010 $1,625
Q3 2010 $1,831
Q2 2010 $1,799
Q1 2009 $1,869
Q4 2009 $1,724
Q3 2009 $1,820
Q2 2009 $1,725
Q1 2008 $1,718
Q4 2008 $1,596
Q3 2008 $1,849
Q2 2008 $1,747
Q1 2007 $1,706
Q4 2007 $1,574
Q3 2007 $1,631
Q2 2007 $1,576
Q1 2006 $1,502
Q4 2006 $1,463
Q3 2006 $1,457
Q2 2006 $1,424
Q1 2005 $1,394
Q4 2005 $1,306
Q3 2005 $1,381
Q2 2005 $1,366
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $62.968B $12.093B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $25.317B 9.69
Align Technology (ALGN) United States $25.238B 67.29
AmerisourceBergen (ABC) United States $19.520B 14.19
Laboratory Of America Holdings (LH) United States $17.257B 15.87
Cardinal Health (CAH) United States $15.596B 10.84
Henry Schein (HSIC) United States $12.561B 21.42
Cooper (COO) United States $12.495B 22.50
West Pharmaceutical Services (WST) United States $8.382B 43.34
DENTSPLY SIRONA (XRAY) United States $8.000B 14.00
Merit Medical Systems (MMSI) United States $3.405B 44.75
Patterson (PDCO) United States $2.197B 15.44
CONMED (CNMD) United States $2.013B 34.10
STAAR Surgical (STAA) United States $1.834B 245.47
Atrion (ATRI) United States $1.258B 37.29
Antares Pharma (ATRS) United States $0.535B 0.00
Invacare (IVC) United States $0.468B 0.00
Lifevantage (LFVN) United States $0.152B 21.58
Endologix (ELGX) United States $0.127B 0.00
Aceto (ACET) United States $0.065B 42.40
Pro-Dex (PDEX) United States $0.041B 25.73
Biolase (BIOL) United States $0.027B 0.00
Retractable Technologies (RVP) United States $0.022B 0.00
Milestone Scientific (MLSS) United States $0.020B 0.00